Dengue and Zika virus domain III-flagellin fusion and glycan-masking E antigen for a prime-boost vaccine design

被引:0
|
作者
Lin, H-H. [1 ]
Yang, S-P. [1 ]
Tsai, M-J. [1 ]
Lin, G-C. [1 ]
Wu, H-C. [2 ]
Wu, S. C. [1 ]
机构
[1] Natl Tsing Hua Univ, Hsinchu, Taiwan
[2] Acad Sinica, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P1087
引用
收藏
页码:1672 / 1672
页数:1
相关论文
共 3 条
  • [1] Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization
    Lin, Hsiao-Han
    Yang, Shao-Ping
    Tsai, Meng-Ju
    Lin, Guan-Cheng
    Wu, Han-Chung
    Wu, Suh-Chin
    THERANOSTICS, 2019, 9 (16): : 4811 - 4826
  • [2] Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges
    Chen, Chi-Hsun
    Chen, Chung-Chu
    Wang, Wei-Bo
    Lionel, Vania
    Liu, Chia-Chyi
    Huang, Li-Min
    Wu, Suh-Chin
    PHARMACEUTICS, 2022, 14 (05)
  • [3] Heterologous prime-boost vaccination with DNA vaccine and recombinant subunit containing four serotypes of dengue virus envelope protein domain III elicits neutralizing antibodies and specific T-cell responses
    Pan, Chien-Hsiung
    Hu, Hui-mei
    Hsiao, Yu-Ju
    Wu, Sze-Hsien
    JOURNAL OF IMMUNOLOGY, 2013, 190